1. Search Result
Search Result
Results for "

mCRPC

" in MCE Product Catalog:
Cat. No. Product Name Target Research Areas
  • HY-128938
    EC1167

    Others Cancer
    EC1167 is the linker for EC1169. EC1169 is prostate-specific membrane antigen targeting-tubulysin conjugate. EC1169 has the potential to treat recurrent metastatic, castration-resistant prostate cancer (MCRPC).
  • HY-137448
    Rezvilutamide

    SHR3680

    Androgen Receptor Cancer
    Rezvilutamide (SHR3680) is an androgen receptor antagonist. Rezvilutamide (SHR3680) is used for the study of prostate cancer.